Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
20
INO Quote, Financials, Valuation and Earnings
Last price:
$1.38
Seasonality move
:
-5.79%
Day range:
$1.31 - $1.35
52-week range:
$1.30 - $12.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.96x
Volume:
1.3M
Avg. volume:
2.3M
1-year change:
-87.96%
Market cap:
$49.1M
Revenue:
$217.8K
EPS (TTM):
-$3.19
Earnings Data
Next earnings date for INO
Aug 08
2025
Most recent earnings per share
-$0.51
Beat by $0.23
(May 13/2025)
Consensus Estimate
-$0.74
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
INO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $8.3K | -- | -- | -$0.57 | -- |
| 08/08/2025 | Q2 | $8.3K | -- | -- | -$0.62 | -- |
| 05/13/2025 | Q1 | $10K | $65.3K | -$0.51 | -$0.74 | $0.23 |
| 03/18/2025 | Q4 | $25K | $117K | -$0.60 | -$0.83 | $0.23 |
| 11/14/2024 | Q3 | $104.5K | -- | -$0.89 | -$1.13 | $0.24 |
| 08/08/2024 | Q2 | $121.5K | $100.8K | -$1.19 | -$1.10 | -$0.09 |
| 05/13/2024 | Q1 | $150.8K | -- | -$1.31 | -$0.99 | -$0.32 |
| 03/06/2024 | Q4 | $344.1K | $102.7K | -$1.08 | -$1.24 | $0.16 |
| 11/09/2023 | Q3 | $262.5K | $388.5K | -$1.52 | -$1.50 | -$0.02 |
| 08/09/2023 | Q2 | $262.5K | $226K | -$1.61 | -$1.72 | $0.11 |
| 05/10/2023 | Q1 | -- | $114.9K | -$1.89 | -- | -- |
| 03/01/2023 | Q4 | -- | $124.7K | -$2.55 | -- | -- |
| 11/08/2022 | Q3 | -- | $9.2M | -$1.80 | -- | -- |
| 08/09/2022 | Q2 | -- | $784.4K | -$5.52 | -- | -- |
| 05/10/2022 | Q1 | -- | $199.1K | -$4.32 | -- | -- |
| 03/01/2022 | Q4 | -- | $839.1K | -$6.05 | -- | -- |
| 11/09/2021 | Q3 | -- | $291.7K | -$3.48 | -- | -- |
| 08/09/2021 | Q2 | -- | $272.8K | -$4.68 | -- | -- |
| 05/10/2021 | Q1 | -- | $371.1K | -$3.24 | -- | -- |
| 03/01/2021 | Q4 | -- | $5.6M | -$1.32 | -- | -- |
| 11/09/2020 | Q3 | -- | $236.2K | $1.32 | -- | -- |
| 08/10/2020 | Q2 | -- | $267.2K | -$9.96 | -- | -- |
| 05/11/2020 | Q1 | -- | $1.3M | -$3.12 | -- | -- |
| 03/12/2020 | Q4 | -- | $279.5K | -$4.56 | -- | -- |
| 11/12/2019 | Q3 | -- | $866.9K | -$3.00 | -- | -- |
| 08/08/2019 | Q2 | -- | $135.7K | -$3.60 | -- | -- |
| 05/09/2019 | Q1 | -- | $2.8M | -$3.60 | -- | -- |
| 03/12/2019 | Q4 | -- | $2.5M | -$4.20 | -- | -- |
| 11/08/2018 | Q3 | -- | $2M | -$3.24 | -- | -- |
| 08/07/2018 | Q2 | -- | $24.4M | -$0.96 | -- | -- |
| 05/09/2018 | Q1 | -- | $1.5M | -$4.32 | -- | -- |
| 03/14/2018 | Q4 | -- | $8.8M | -$2.88 | -- | -- |
| 11/08/2017 | Q3 | -- | $2.6M | -$4.80 | -- | -- |
| 08/08/2017 | Q2 | -- | $20.4M | -$1.56 | -- | -- |
| 05/10/2017 | Q1 | -- | $10.4M | -$3.72 | -- | -- |
| 03/15/2017 | Q4 | -- | $8.5M | -$4.32 | -- | -- |
| 11/09/2016 | Q3 | -- | $12.5M | -$3.36 | -- | -- |
| 08/08/2016 | Q2 | -- | $6.2M | -$3.12 | -- | -- |
| 05/09/2016 | Q1 | -- | $8.1M | -$1.32 | -- | -- |
| 03/14/2016 | Q4 | -- | $5.9M | -$3.12 | -- | -- |
| 11/09/2015 | Q3 | -- | $24.2M | $0.84 | -- | -- |
Inovio Pharmaceuticals Earnings Questions
-
How Much did Inovio Pharmaceuticals Generate in Revenue Last Quarter?
Inovio Pharmaceuticals reported $65.3K worth of top line sales in its most recent quarter.
-
Did Inovio Pharmaceuticals Beat Earnings Last Quarter?
Inovio Pharmaceuticals announced earnings per share of -$0.51 which represents a beat of analyst forecast a -$0.74 per share.
-
Is Inovio Pharmaceuticals Profitable?
Inovio Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Inovio Pharmaceuticals EPS Next Year?
Inovio Pharmaceuticals's earnings are forecast to decrease from -$3.95 per share to -$4.21 per share next year representing a decrease of -40.76%.
-
When is Inovio Pharmaceuticals's Earnings Date?
Inovio Pharmaceuticals's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
